Continuous-flow left ventricular assist device implantation followed by heart transplantation in patient with endarteritis obliterans and high pulmonary hypertension
Abstract
Heart transplantation and the left ventricular assist device implantation as “bridge to transplantation” or “destination therapy” are surgical methods of the end-stage heart failure treatment. Despite the latest achievements in this field of medicine, these methods have contraindications. The results of the left ventricular assist device implantation followed by heart transplantation in patient with endarteritis obliterans and high pulmonary hypertension are described in this case report.
Keywords:left ventricular assist device, mechanical circulatory support, heart failure, heart transplantation, endarteritis obliterans
For citation: Pya Yu.V., Bekbossynova M.S., Andossova S.A., Dzhetybayeva S.K., Medressova A.T., Khissamutdinov N.F., Bekbossynov S.T., Novikova S.P., Tauyekelova A.T., Kaliyev R.B., Smagulov N.K. Continuous-flow left ventricular assist device implantation followed by heart transplantation in patient with endarteriitisobliterans and high pulmonary hypertension. Clin Experiment Surg. Petrovsky J. 2019; 7 (3): 40–3. doi: 10.24411/2308-1198-2019-13004 (in Russian)
Received 22.06.2019. Accepted 25.07.2019.
References
1. Ponikowski P., Voors A.A., Anker S.D., Bueno H., et al.; ESC Scientific Document Group. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016; 37 (27): 2129-200. doi: 10.1093/eurheartj/ehw128.
2. Kormos R.L., Cowger J., Pagani F.D., Teuteberg J.J., et al. The Society of Thoracic Surgeons Intermacs Database Annual Report: Evolving Indications, Outcomes, and Scientific Partnerships. Ann Thorac Surg 2019; 107 (2): 341-53. doi: 10.1016/j.athoracsur.2018.11.011.
3. Falletta С., Pasta S., Raffa G.M., Crino F., et al. Peripheral artery disease and continuous flow left ventricle assist device: an engaging complement analysis may help to guide treatment. Artif Organs. 2018; 42 (7): 756-9. doi: 10.1111/aor.13105.
4. Feldman D., Pamboukian S.V., Teuteberg J.J., Birks E., et al.; International Society for Heart and Lung Transplantation. The 2013 International Society for Heart and Lung Transplantation guidelines for mechanical circulatory support: executive summary. J Heart Lung Transplant. 2013; 32 (2): 157-87. doi: 10.1016/j.healun.2012.09.013.
5. Lund L.H., Matthews J., Aaronson K. Patient selection for left ventricular assist devices. Eur J Heart Fail. 2010; 12 (5): 434-43. doi: 10.1093/eurjhf/hfq006.
6. Mehra M.R., Canter C.E., Hannan M.M., Semigran M.J., et al.; International Society for Heart Lung Transplantation (ISHLT) Infectious Diseases Council; Internation- al Society for Heart Lung Transplantation (ISHLT) Pediatric Transplantation Council; International Society for Heart Lung Transplantation (ISHLT) Heart Failure and Transplantation Council. The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: a 10-year update. J Heart Lung Transplant. 2016; 35 (1): 1-23. doi: 10.1016/j.healun.2015.10.023.
7. Mehra M.R., Kobashigawa J., Starling R., Russell S., et al. Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates - 2006. J Heart Lung Transplant. 2006; 25: 1024-42.
8. StevensonL.W.,PaganiF.D.,YoungJ.B.,JessupM., et al. INTERMACS profiles of advanced heart failure: the current picture. J Heart Lung Transplant. 2009; 28 (6): 535-41.
9. Garbade J., Bittner H.B., Barten M.J., Mohr F.-W. Current trends in implantable left ventricular assist devices. Cardiol Res Pract. 2011; 2011: 290561. doi: 10.4061/2011/290561.
10. Witman M.A., Garten R.S., Gifford J.R., Groot H.J., et al. Further peripheral vascular dysfunction in heart failure patients with a continuous-flow left ventricular assist device. JACC Heart Fail. 2015; 3 (9): 703-11. doi: 10.1016/j.jchf.2015.04.012.
11. Idris A., Al-Khadra Y., Kabach A., Darmoch F., et al. The impact of peripheral arterial disease on advanced heart failure patients undergoing left ventricular assist device surgery. Eur Heart J. 2018; 39 (1): 1834. doi: 10.1093/eurheartj/ehy565.P1834.